Health Trials

Nerve Sheath Tumor

2

Review clinical trials related to Nerve Sheath Tumor. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

This is a single-center, pilot, PET-imaging study of the novel radiotracer 89Zirconium-89 DFO conjugated to the YS5 monoclonal antibody (\[89Zr\]DFO-YS5) in participants with nerve sheath tumor, bladder cancer, or advanced solid tumor neoplasms.

Participants needed: 40
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Robert Flavell, MD, PhDUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

Histological or cytological confirmation of malignant peripheral nerve sheath tu... [+11]

Individuals with a contraindication to PET-CT imaging (e.g., severe claustrophob... [+3]

Read more
Status: Recruiting

Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors

The goal of this clinical trial is to evaluate the efficacy and safety of FCN-159 in patients with specific NF2-associated nerve sheath tumors.

Participants needed: 30
Trial details
Phase: Phase 2Age: 16+Biological sex: AllType: InterventionalSponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesUpdated: Jul 29, 2025Locations: 1
Eligibility criteria

≥16 years of age, regardless of gender. [+9]

Pharmaceutical or biological therapy within 3 weeks or 5 half-lives prior to enr... [+6]

Read more